logo
Search orAI Icon𝛼SK
ENTITY

MetaVia (MTVA US)

14
Analysis
Health Care • United States
MetaVia Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing dual oxyntomodulin (OXM) analog agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). MetaVia serves customers worldwide.
more
Company Event • 20 Mar 2026 12:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 06 Nov 2025 21:30 • Upcoming
Add To Calendar

Q3 2025

Company Event • 07 Aug 2025 20:30 • Upcoming
Add To Calendar

Q2 2025

Company Event • 13 Jun 2025 01:00 • Latest

Life Sciences Investor Forum

Company Event • 22 May 2025 04:25

Emerging Growth Conference 82

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x